Please assess the completion status of the following clinical trial:

Trial Title: The STAR™ Tumor Ablation Registry

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects with painful spinal metastatic lesions in thoracolumbar vertebrae (T1-L5) that will be treated with t-RFA using the STAR™ Tumor Ablation System.~* Have signed informed consent~Exclusion Criteria:~* Subjects under 18 years old~* Subjects with heart pacemakers, or other electronic device implants~* Subjects intended for t-RFA in vertebral body levels C1-7

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients receiving Targeted Radiofrequency Ablation (t-RFA) (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).